Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The conversation around obesity is shifting toward one of a chronic disease rather than a lifestyle choice
In the SURPASS-4 trial, adults with T2DM at heightened cardiovascular risk, who were inadequately managed with oral glucose-lowering agents, once-weekly tirzepatide (5 mg, 10 mg, or 15 mg) were compared to insulin glargine (100 U/mL)
Paired with liposuction, these may boost your results
Rotation of injection sites prevents localized tissue irritation and ensures consistent absorption
US$ 22.69
US$ 20.83
US$ 28.47
US$ 29.45
US$ 27.35
US$ 23.34
US$ 29.88
US$ 21.55
